Suspension of trading
Quotes Amicus Therapeutics, Inc.
Stocks
FOLD
US03152W1099
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-04-24 EDT
|
5-day change | 1st Jan Change | ||
| 14.49 USD | +0.21% |
|
-.--% | +1.76% |
| 05-05 | BioMarin Enters 'Transition Year' as Enzyme Portfolio Expands After Amicus Deal, Morgan Stanley Says | MT |
| 04-28 | Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from S&P Global BMI Index | CI |
Stock exchange
Nasdaq
FOLD 14.49 $
+0.21%
76.58M
$
| Markets | Price | Change | Volumes |
|---|
Performance
| 1 day | +0.21% | ||
| 6 months | +0.91% | ||
| Current year | +1.76% | ||
| 1 year | +90.41% | ||
| 3 years | +14.27% | ||
| 5 years | +33.06% | ||
| 10 years | +107.00% |
Volumes
marketsDaily volume
5,285,334
Estimated daily volume
5,285,334
Record volume 1
188,236,354
Record volume 2
55,625,760
Record volume 3
38,443,411
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
4,549,870,316
Net sales ()
634,210,000
Number of employees
511
Sales / Employee (USD)
1,241,115
Free-Float
99.31 %
Free-Float capitalization (USD)
4,518,668,593
Indicators
Moving average 5 days
14.47
Moving average 100 days
13.77
Price spread / (MMA5)
-0.17%
Price spread / (MMA100)
-4.98%
STIM
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.21% | -.--% | +90.41% | +14.27% | 4.55B | |
| -0.74% | +3.78% | +3.74% | +23.10% | 51.61B | |
| +1.01% | -0.20% | +471.68% | +564.93% | 44.89B | |
| +0.16% | +7.88% | +36.14% | +20.76% | 42.77B | |
| -0.66% | +2.61% | +18.59% | +87.04% | 42.58B | |
| +0.88% | -3.48% | +17.20% | +53.83% | 31.82B | |
| -0.12% | +3.84% | +33.73% | +145.25% | 17.33B | |
| -0.53% | +1.84% | - | - | 16.63B | |
| +0.58% | +4.66% | +7.17% | +30.87% | 14.76B | |
| +1.15% | +4.17% | +84.49% | +50.33% | 14.09B | |
| Average | +0.19% | +3.79% | +84.80% | +110.04% | 28.1B | |
| Weighted average by Cap. | +0.10% | +4.04% | +100.40% | +138.46% |
Historical Quotes: Amicus Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| Current year | 14.2 |  | 14.5 |
| 1 year | 7.4 | | 14.5 |
| 3 years | 5.51 | | 14.57 |
| 5 years | 5.51 | | 14.57 |
| 10 years | 4.41 | | 25.39 |
Monthly variations
Annual variations
| 2026 | +1.76% | ||
| 2025 | +51.17% | ||
| 2024 | -33.62% | ||
| 2023 | +16.22% | ||
| 2022 | +5.71% | ||
| 2021 | -49.98% | ||
| 2020 | +137.06% | ||
| 2019 | +1.67% | ||
| 2018 | -33.43% | ||
| 2017 | +189.54% | ||
| 2016 | -48.76% | ||
| 2015 | +16.59% | ||
| 2014 | +254.04% | ||
| 2013 | -12.31% | ||
| 2012 | -22.09% | ||
| 2011 | -26.81% | ||
| 2010 | +18.39% | ||
| 2009 | -50.25% | ||
| 2008 | -25.77% | ||
| 2007 | -25.50% |
- Stock Market
- Stocks
- FOLD Stock
- Quotes Amicus Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
